Cargando…

Adaptive two-stage bioequivalence trials with early stopping and sample size re-estimation

Detalles Bibliográficos
Autores principales:	Koenig, Franz, Wolfsegger, Martin, Jaki, Thomas, Schütz, Helmut, Wassmer, Gernot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660334/ http://dx.doi.org/10.1186/1745-6215-16-S2-P218

Ejemplares similares

Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials
por: Magirr, Dominic, et al.
Publicado: (2016)

Interim sample size re-estimation in the IIVOP trial
por: Dawson, Sarah, et al.
Publicado: (2015)

Sample Size Determination for Individual Bioequivalence Inference
por: Chiang, Chieh, et al.
Publicado: (2014)

Follow up after sample size re-estimation in a breast cancer trial for time to recurrence
por: Hade, Erinn, et al.
Publicado: (2013)

A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials
por: Bowden, J, et al.
Publicado: (2014)

Model selection and sample size adaptation: HYPAZ trial
por: Bond, Simon, et al.
Publicado: (2011)

Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairment
por: Wang, Guoqiao, et al.
Publicado: (2015)

Design and estimation in clinical trials with subpopulation selection
por: Chiu, Yi‐Da, et al.
Publicado: (2018)

Estimating the Risk of Re-Emergence after Stopping Polio Vaccination
por: Sasaki, Akira, et al.
Publicado: (2012)

Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19
por: Stallard, Nigel, et al.
Publicado: (2020)

Optimal design for multi-arm multi-stage clinical trials
por: Wason, James MS, et al.
Publicado: (2011)

Blinded sample size re-estimation in a comparative diagnostic accuracy study
por: Stark, Maria, et al.
Publicado: (2022)

Application of sample size re-estimation in clinical trials: A systematic review
por: Mano, Hirotaka, et al.
Publicado: (2023)

Treatment selection in multi-arm, multi-stage clinical trials
por: Jaki, Thomas, et al.
Publicado: (2013)

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013)

Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications
por: Graf, Alexandra C, et al.
Publicado: (2014)

Estimation after blinded sample size reassessment
por: Posch, Martin, et al.
Publicado: (2016)

Sample size re-estimation in crossover trials: application to the AIM HY-INFORM study
por: Wych, Julie, et al.
Publicado: (2019)

Determining the sample size for a cluster-randomised trial: Bayesian hierarchical modelling of the ICC estimate
por: Tishkovskaya, Svetlana, et al.
Publicado: (2015)

PB.1. Axillary lymph node ultrasound and needle sampling in preoperative staging of breast cancer: re-audit
por: Hamilton, P, et al.
Publicado: (2014)

Optimizing subgroup selection in two‐stage adaptive enrichment and umbrella designs
por: Ballarini, Nicolás M., et al.
Publicado: (2021)

Effect of Study Design on Sample Size in Studies Intended to Evaluate Bioequivalence of Inhaled Short‐Acting β‐Agonist Formulations
por: Zeng, Yaohui, et al.
Publicado: (2017)

Twenty‐five years of confirmatory adaptive designs: opportunities and pitfalls
por: Bauer, Peter, et al.
Publicado: (2015)

Sample size estimation
por: Chander, N. Gopi
Publicado: (2017)

Adaptive designs for phase II cross-over dose-finding trials using Bayesian model averaging
por: Simpson, Sarah, et al.
Publicado: (2015)

Sample size re-estimation in paired comparative diagnostic accuracy studies with a binary response
por: McCray, Gareth P. J., et al.
Publicado: (2017)

A post hoc analysis of intra-subject coefficients of variation in pharmacokinetic measures to calculate optimal sample sizes for bioequivalence studies
por: Chung, Inbum, et al.
Publicado: (2018)

A post hoc analysis of intra-subject coefficients of variation in pharmacokinetic measures to calculate optimal sample sizes for bioequivalence studies
por: Chung, Inbum, et al.
Publicado: (2017)

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations
por: Zhao, Xiao-Ying, et al.
Publicado: (2013)

Stratum Corneum Sampling to Assess Bioequivalence between Topical Acyclovir Products
por: Pensado, A., et al.
Publicado: (2019)

Evaluation of model‐based bioequivalence approach for single sample pharmacokinetic studies
por: Tardivon, Coralie, et al.
Publicado: (2023)

Group sequential and confirmatory adaptive designs in clinical trials
por: Wassmer, Gernot, et al.
Publicado: (2016)

IntReALL HR and the benefits of adaptive design
por: Holmes, Jane, et al.
Publicado: (2015)

Coping with clustering in sample size calculations
por: Playle, Rebecca, et al.
Publicado: (2011)

Bioequivalence: tried and tested
por: Schall, Robert, et al.
Publicado: (2010)

Bioequivalence studies in Morocco
por: Zaoui, Sanaa, et al.
Publicado: (2020)

Bioequivalence data analysis
por: Park, Gowooni, et al.
Publicado: (2020)

Sample size re-estimation without un-blinding for time-to-event outcomes in oncology clinical trials
por: Huang, Li-Hong, et al.
Publicado: (2018)

Validation of a Bayesian Adaptive Estimation Technique in the Stop-Signal Task
por: Livesey, Evan J., et al.
Publicado: (2016)

A neuro-mechanical model containing fast and slow muscle fibres applied to mimic stop and re-start of a stepping leg
por: Daun-Gruhn, Silvia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kj7evcb54qkopit7rt61i9485c